These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 16546751)
1. [Association of peripheral blood estradiol, progesterone and testosterone levels with irritable bowel syndrome]. Cui N; Wu BP; Wu SZ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):367-8. PubMed ID: 16546751 [TBL] [Abstract][Full Text] [Related]
2. Male sex hormones may influence the symptoms of irritable bowel syndrome in young men. Kim BJ; Rhee PL; Park JH; Chang DK; Kim YH; Son HJ; Kim JJ; Rhee JC; Lee H Digestion; 2008; 78(2-3):88-92. PubMed ID: 18974649 [TBL] [Abstract][Full Text] [Related]
3. Correlation of gut hormones with irritable bowel syndrome. Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690 [TBL] [Abstract][Full Text] [Related]
4. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms? Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321 [TBL] [Abstract][Full Text] [Related]
5. Do male sex hormones protect from irritable bowel syndrome? Houghton LA; Jackson NA; Whorwell PJ; Morris J Am J Gastroenterol; 2000 Sep; 95(9):2296-300. PubMed ID: 11007231 [TBL] [Abstract][Full Text] [Related]
6. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Dinan TG; Clarke G; Quigley EM; Scott LV; Shanahan F; Cryan J; Cooney J; Keeling PW Am J Gastroenterol; 2008 Oct; 103(10):2570-6. PubMed ID: 18785949 [TBL] [Abstract][Full Text] [Related]
7. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome]. Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369 [TBL] [Abstract][Full Text] [Related]
8. Sex hormone ratio changes in men and postmenopausal women with coronary artery disease. He H; Yang F; Liu X; Zeng X; Hu Q; Zhu Q; Tu B Menopause; 2007; 14(3 Pt 1):385-90. PubMed ID: 17108845 [TBL] [Abstract][Full Text] [Related]
9. 17-beta-estradiol and progesterone serum levels in temporomandibular disorder patients. Landi N; Manfredini D; Lombardi I; Casarosa E; Bosco M Minerva Stomatol; 2004; 53(11-12):651-60. PubMed ID: 15894940 [TBL] [Abstract][Full Text] [Related]
10. High interdigestive and postprandial motilin levels in patients with the irritable bowel syndrome. Simrén M; Björnsson ES; Abrahamsson H Neurogastroenterol Motil; 2005 Feb; 17(1):51-7. PubMed ID: 15670264 [TBL] [Abstract][Full Text] [Related]
11. Plasma progesterone, estradiol-17 beta and testosterone in maternal and cord blood, and maternal human chorionic gonadotropin at parturition. Adeyemo O; Jeyakumar H Afr J Med Med Sci; 1993 Sep; 22(3):55-60. PubMed ID: 7839913 [TBL] [Abstract][Full Text] [Related]
12. Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome? Elsenbruch S; Holtmann G; Oezcan D; Lysson A; Janssen O; Goebel MU; Schedlowski M Am J Gastroenterol; 2004 Apr; 99(4):703-10. PubMed ID: 15089905 [TBL] [Abstract][Full Text] [Related]
13. T-cell activation in patients with irritable bowel syndrome. Ohman L; Isaksson S; Lindmark AC; Posserud I; Stotzer PO; Strid H; Sjövall H; Simrén M Am J Gastroenterol; 2009 May; 104(5):1205-12. PubMed ID: 19367268 [TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter gene polymorphism and irritable bowel syndrome. Park JM; Choi MG; Park JA; Oh JH; Cho YK; Lee IS; Kim SW; Choi KY; Chung IS Neurogastroenterol Motil; 2006 Nov; 18(11):995-1000. PubMed ID: 17040410 [TBL] [Abstract][Full Text] [Related]
15. [The sex hormone content of the peripheral blood in women with gonorrhea and gonorrhea-trichomoniasis infections]. Iagovdik NZ; Evseenko IA Vestn Dermatol Venerol; 1990; (8):35-8. PubMed ID: 2256376 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. Han SH; Lee OY; Bae SC; Lee SH; Chang YK; Yang SY; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH; Kim TH J Gastroenterol Hepatol; 2006 Nov; 21(11):1687-92. PubMed ID: 16984590 [TBL] [Abstract][Full Text] [Related]
18. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. El-Salhy M; Lomholt-Beck B; Hausken T Scand J Gastroenterol; 2010 Dec; 45(12):1435-9. PubMed ID: 20602602 [TBL] [Abstract][Full Text] [Related]
19. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study. Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Rahimi R; Nikfar S; Abdollahi M Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]